Wells Fargo
GOCO

Wells Fargo’s GoHealth GOCO Stock Holding History

Wells Fargo’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,650
Closed -$5.51K – 7416
2026
Q1 		$5.51K Sell
3,650
-7,013
-66% -$13.4K ﹤0.01% 6096
2025
Q4 		$22.9K Buy
10,663
+6,454
+153% +$22K ﹤0.01% 5757
2025
Q3 		$20.3K Buy
4,209
+985
+31% +$5.38K ﹤0.01% 5798
2025
Q2 		$17.9K Buy
3,224
+404
+14% +$3.19K ﹤0.01% 5814
2025
Q1 		$34.6K Buy
2,820
+60
+2% +$916 ﹤0.01% 5511
2024
Q4 		$37K Buy
2,760
+607
+28% +$6.9K ﹤0.01% 5577
2024
Q3 		$20.2K Buy
2,153
+88
+4% +$891 ﹤0.01% 5638
2024
Q2 		$20.1K Buy
2,065
+507
+33% +$5.01K ﹤0.01% 5585
2024
Q1 		$16.4K Sell
1,558
-1,003
-39% -$12.4K ﹤0.01% 5634
2023
Q4 		$34.2K Buy
2,561
+309
+14% +$4.23K ﹤0.01% 5413
2023
Q3 		$32.6K Sell
2,252
-530
-19% -$9.13K ﹤0.01% 5391
2023
Q2 		$54.8K Buy
2,782
+1,402
+102% +$22K ﹤0.01% 5389
2023
Q1 		$22.5K Sell
1,380
-82
-6% -$1.27K ﹤0.01% 5587
2022
Q4 		$15.3K Buy
1,462
+2
+0.1% +$18 ﹤0.01% 5374
2022
Q3 		$8K Buy
1,460
+88
+6% +$663 ﹤0.01% 5759
2022
Q2 		$12K Sell
1,372
-150
-10% -$1.74K ﹤0.01% 5669
2022
Q1 		$27K Sell
1,522
-1,227
-45% -$38.2K ﹤0.01% 5905
2021
Q4 		$156K Sell
2,749
-117,189
-98% -$7.82M ﹤0.01% 5402
2021
Q3 		$9.05M Buy
119,938
+103,045
+610% +$10.9M ﹤0.01% 2302
2021
Q2 		$2.84M Sell
16,893
-180,206
-91% -$31.6M ﹤0.01% 3384
2021
Q1 		$34.6M Buy
197,099
+192,591
+4,272% +$38.8M 0.01% 1261
2020
Q4 		$924K Buy
4,508
+4,271
+1,802% +$793K ﹤0.01% 4087
2020
Q3 		$46K Buy
+237
New +$57.1K ﹤0.01% 5538

Other funds holding GOCO

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wells Fargo's GOCO Position: Q2 2026 in Review

Wells Fargo sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 3,650 shares — an estimated $5.51K sold.

Wells Fargo first reported a position in GOCO in Q3 2020 and held it in 23 quarters. The position peaked at $34.6M in Q1 2021. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Wells Fargo reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • Wells Fargo sold 3,650 GoHealth shares in Q2 2026, an estimated $5.51K.
  • Wells Fargo first reported a position in GoHealth in Q3 2020 and held it in 23 quarters.
  • Wells Fargo's GoHealth position peaked at $34.6M in Q1 2021.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.